The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
The state has filed a complaint in the U.S. District Court for the District of Rhode Island that accuses the PBMs of violating the federal Deceptive Trade Practices Act.
The proposed settlement would "resolve all of the claims against the Caremark respondents" and already has been approved by CVS, FTC attorneys and the FTC's competition and consumer protection bureaus."
However, the site is lagging far behind Ro.com — a telehealth services and anti-obesity drug provider — but crushing the Mark Cuban Cost Plus Drug Company's CostPlusDrugs.com site.
Although the PBM did not admit liability, it agreed to reimburse pharmacies with interest and revise internal policies to comply with West Virginia law.
The sweeping complaint includes pharmacy benefit managers Express Scripts, Evernorth, CVS Caremark and Optum Rx; insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi; and group purchasing organizations.